<DOC>
	<DOC>NCT00711919</DOC>
	<brief_summary>This study is aimed to analyze the effects of aggressive and conventional lipid lowering therapy with Pravastatin on carotid intima-media thickness (IMT) in patients with hyperlipidemia and abnormal thickening of IMT.</brief_summary>
	<brief_title>Pitavastatin on Carotid Intima-media Thickness</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Diagnosed as having hyperlipidemia LDLC at the time of enrollment is no less than 100 Common carotid IMT is 1.1 mm and over Received or planned to receive intervention on carotid arteries during the study period Overt liver dysfunction (ALT; 100 IU/L and over) Overt renal dysfunction (serum creatinine; 2.0 mg/dL and over) Receiving Cyclosporin Hyperreactive to Pitavastatin During pregnancy or lactation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>